Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 19.47 is in line with its 5-year average of 17.96, around the middle of its 5-year range (3.70–37.98).
As of the fiscal period ended Tuesday, June 30, 2026. 0.23% above its 12-month average of 19.42.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 19.47.
QUICK RATIO (ACID-TEST)
19.47
QUICK RATIO (ACID-TEST) AVG TTM
19.42
QUICK RATIO (ACID-TEST) AVG 3Y
14.71
QUICK RATIO (ACID-TEST) AVG 5Y
17.96
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+0.23%
CURRENT VS 3Y AVG
+32.34%
CURRENT VS 5Y AVG
+8.41%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.99
median of 635 covered companies
CURRENT VS SECTOR MEDIAN
+551.08%
vs the sector median at left
Immuneering Corporation
Market Cap
$144.48M
Quick Ratio (Acid-Test)
19.47
TTM Avg
19.42
3Y Avg
14.71
5Y Avg
17.96
Market Cap
$144.00M
Quick Ratio (Acid-Test)
0.82
TTM Avg
5.49
3Y Avg
4.19
5Y Avg
4.19
Market Cap
$150.23M
Quick Ratio (Acid-Test)
2.47
TTM Avg
5.26
3Y Avg
13.15
5Y Avg
16.36
Market Cap
$147.13M
Quick Ratio (Acid-Test)
1.23
TTM Avg
1.14
3Y Avg
1.35
5Y Avg
4.96
Market Cap
$147.97M
Quick Ratio (Acid-Test)
0.84
TTM Avg
0.97
3Y Avg
0.83
5Y Avg
1.00
Market Cap
$142.15M
Quick Ratio (Acid-Test)
0.79
TTM Avg
0.57
3Y Avg
0.67
5Y Avg
0.95
Market Cap
$139.73M
Quick Ratio (Acid-Test)
3.83
TTM Avg
1.68
3Y Avg
1.58
5Y Avg
2.46
Market Cap
$139.63M
Quick Ratio (Acid-Test)
8.04
TTM Avg
11.45
3Y Avg
6.05
5Y Avg
5.52
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Immuneering Corporation (IMRX) | $144.48M | 19.47 | 19.42 | 14.71 | 17.96 |
| Korsana Biosciences, Inc. (KRSA)vs › | $144.00M | 0.82 | 5.49 | 4.19 | 4.19 |
| Nyxoah S.A. (NYXH)vs › | $142.60M | 2.31 | 2.75 | 4.17 | 7.24 |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $150.23M | 2.47 | 5.26 | 13.15 | 16.36 |
| NervGen Pharma Corp. Common stock (NGEN)vs › | $147.13M | 1.23 | 1.14 | 1.35 | 4.96 |
| LifeMD, Inc. (LFMDP)vs › | $147.97M | 0.84 | 0.97 | 0.83 | 1.00 |
| AirSculpt Technologies, Inc. (AIRS)vs › | $142.15M | 0.79 | 0.57 | 0.67 | 0.95 |
| Fortress Biotech, Inc. (FBIOP)vs › | $139.73M | 3.83 | 1.68 | 1.58 | 2.46 |
| Alpha Cognition Inc (ACOG)vs › | $139.63M | 8.04 | 11.45 | 6.05 | 5.52 |
| Cardiol Therapeutics Inc. (CRDL)vs › | $151.01M | 5.55 | 4.34 | 4.83 | 5.44 |
Quick Ratio
19.47
Excludes inventory
Current Ratio
19.47
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 19.47 |
| 2026-03-31 | 32.45 |
| 2025-12-31 | 17.50 |
| 2025-09-30 | 24.00 |
| 2025-06-30 | 3.70 |
| 2025-03-31 | 7.48 |
| 2024-12-31 | 5.28 |
| 2024-09-30 | 7.99 |
| 2024-06-30 | 9.39 |
| 2024-03-31 | 14.38 |
| 2023-12-31 | 11.35 |
| 2023-09-30 | 17.89 |
| 2023-06-30 | 20.35 |
| 2023-03-31 | 17.05 |
| 2022-12-31 | 13.50 |
| 2022-09-30 | 16.54 |
| 2022-06-30 | 33.99 |
| 2022-03-31 | 37.98 |
| 2021-12-31 | 27.04 |
| 2021-09-30 | 29.11 |
| 2021-06-30 | 10.65 |
| 2021-03-31 | 11.67 |
| 2020-12-31 | 16.73 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
